Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
505.00    4.50 (0.90%)
Bid:
505.00
Ask:
505.50
Spread: 0.50 (0.099%)
Market Cap: £2.23b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

20260521_TATE & LYLE_8.5 EPT RI_UK_MLI_replacement

1 Jun 2026 16:55

RNS Number : 5323G
Bank of America Merrill Lynch
01 June 2026
 

FORM 8.5 Replacement

 

 

The Form 8.5 Tate & Lyle Plc announcement released on 22/05/2026 under RNS 4811F has been amended.

 

Amendments are identified with an asterisk (*).

 

 

 

The full amended text is shown below

 

 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")

 

1.

KEY INFORMATION

(a)

Name of exempt principal trader:

Merrill Lynch International

(b)

Name of offeror/offeree in relation to whoserelevant securities this form relates: Use a separate form for each offeror/offeree

TATE & LYLE PLC

(c)

Name of the party to the offer with which exempt principal trader is connected:

TATE & LYLE PLC

(d)

Date dealing undertaken:

21/05/2026

(e)

In addition to the company in 1(b) above, is theexempt principal trader making disclosures inrespect of any other party to this offer? If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2.

DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional classof relevant security dealt in.The currency of all prices and other monetary amounts should be stated.

 

(a)

Purchases and sales

Class of relevant security

Purchases/sales

Total number of securities

Highest price per unitpaid/received

Lowest price per unitpaid/received

29 1/6p ordinary

Purchase

572,480

5.253150 GBP

5.080000 GBP

29 1/6p ordinary

Sale

*284,438

5.215000 GBP

5.080000 GBP

 

(b)

Cash-settled derivative transactions

 

Class of relevant security

Product descriptione.g. CFD

Nature of dealinge.g. opening/closing a long/short position, increasing/reducing along/short position

Number of reference securities

Price per unit

29 1/6p ordinary

Swaps - Equity Swaps

Reducing a short position

287

5.128821 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Increasing a short position

3,243

5.080102 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Increasing a short position

32,848

5.253150 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Increasing a short position

2,347

5.200650 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Increasing a short position

12,949

5.200650 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Reducing a short position

168

5.145500 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

33,495

5.172210 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

58,253

5.172210 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Increasing a long position

60,753

5.145185 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Reducing a short position

257

5.145500 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

4,369

5.172210 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Reducing a short position

171

5.145500 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Increasing a long position

4,243

5.145185 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Increasing a short position

5,825

5.172210 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

29,126

5.172210 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

13,107

5.172210 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Closing a Long Position

8,209

5.080763 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

7,662

5.099499 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Reducing a long position

1,453

5.099499 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

129,613

5.172210 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

8,738

5.172210 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Increasing a long position

6,053

5.145185 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

191,263

5.206781 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

8,737

5.172210 GBP

 

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class ofrelevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number ofsecurities to which option relates

Exercise priceper unit

Typee.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii)

Exercise

Class of relevant security

Product descriptione.g. call option

Exercising/exercisedagainst

Number of securities

Exercise Price per unit

N/A

N/A

N/A

N/A

N/A

 

(d)

Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealinge.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

 

3.

OTHER INFORMATION

 

(a)

Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or(ii) The voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"

None

 

Date of disclosure:

*01/06/2026

Contact name:

Kamil Dziedzic

Telephone number:

+353 86 168 4821

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory InformationService.The Panel's Market Surveillance Unit is available for consultation in relation to the Code'sdealing disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEREASKFESAKEFA
Date   Source Headline
11th Oct 20245:38 pmRNSTransaction in Own Shares
10th Oct 20245:36 pmRNSTransaction in Own Shares
9th Oct 20245:26 pmRNSTransaction in Own Shares
8th Oct 20245:32 pmRNSTransaction in Own Shares
7th Oct 20245:41 pmRNSTransaction in Own Shares
4th Oct 20245:58 pmRNSTransaction in Own Shares
3rd Oct 20245:34 pmRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSInformation - combination Tate & Lyle / CP Kelco
2nd Oct 20245:47 pmRNSTransaction in Own Shares
1st Oct 20245:32 pmRNSTransaction in Own Shares
1st Oct 202412:00 pmRNSTotal Voting Rights
30th Sep 20245:25 pmRNSTransaction in Own Shares
27th Sep 20245:49 pmRNSTransaction in Own Shares
26th Sep 20245:33 pmRNSTransaction in Own Shares
25th Sep 20245:33 pmRNSTransaction in Own Shares
24th Sep 20243:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20245:45 pmRNSTransaction in Own Shares
20th Sep 20245:40 pmRNSTransaction in Own Shares
19th Sep 20245:51 pmRNSTransaction in Own Shares
18th Sep 20245:31 pmRNSTransaction in Own Shares
17th Sep 20245:33 pmRNSTransaction in Own Shares
16th Sep 20245:40 pmRNSTransaction in Own Shares
13th Sep 20245:32 pmRNSTransaction in Own Shares
12th Sep 20245:41 pmRNSTransaction in Own Shares
11th Sep 20245:35 pmRNSTransaction in Own Shares
10th Sep 20245:42 pmRNSTransaction in Own Shares
9th Sep 20245:27 pmRNSTransaction in Own Shares
9th Sep 202411:00 amRNSHolding(s) in Company
6th Sep 20245:47 pmRNSTransaction in Own Shares
5th Sep 20245:47 pmRNSTransaction in Own Shares
5th Sep 20241:00 pmRNSHolding(s) in Company
4th Sep 20245:58 pmRNSTransaction in Own Shares
3rd Sep 20245:33 pmRNSTransaction in Own Shares
2nd Sep 20245:44 pmRNSTransaction in Own Shares
2nd Sep 20245:00 pmRNSTotal Voting Rights
30th Aug 20245:39 pmRNSTransaction in Own Shares
29th Aug 20245:26 pmRNSTransaction in Own Shares
28th Aug 20245:27 pmRNSTransaction in Own Shares
27th Aug 20245:34 pmRNSTransaction in Own Shares
23rd Aug 20245:49 pmRNSTransaction in Own Shares
22nd Aug 20245:45 pmRNSTransaction in Own Shares
22nd Aug 20244:00 pmRNSDirector/PDMR Shareholding
21st Aug 20246:00 pmRNSTransaction in Own Shares
20th Aug 20245:56 pmRNSTransaction in Own Shares
19th Aug 20245:44 pmRNSTransaction in Own Shares
16th Aug 20245:50 pmRNSTransaction in Own Shares
15th Aug 20245:57 pmRNSTransaction in Own Shares
14th Aug 20245:46 pmRNSTransaction in Own Shares
13th Aug 20245:54 pmRNSTransaction in Own Shares
13th Aug 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.